Published by ICSEB at 1 April, 2025
We are pleased to announce the launch of a new series of virtual meetings in 2025 with the Institut Chiari & Siringomielia & Escoliosis de Barcelona. These sessions aim to address the doubts and difficulties faced by patients with Filum Disease and related conditions.
Each meeting will feature ICSEB specialists who will provide clear explanations on key topics. Participants are welcome to raise general questions in areas such as medical care and treatment options, diagnosis and follow-up protocols, travel planning and logistics, Scheduling and organisational procedures, and more.
Who can attend:
To ensure everyone has the opportunity to participate, each session will be limited to a maximum of 12 participants.
Questions can be submitted in advance via the registration form to help organise the discussion.
After you have submitted the registration form, we will follow up by email to confirm your participation and share the connection details.
For the first time, sessions will also be held specifically for the English-speaking audience. These are organised in collaboration with Unbound Path NGO, and we are pleased to welcome representatives from the organization and other patient advocates, who will share their valuable insight and experience from a patient point of view.
The upcoming sessions will take place on:
Time: 16:00 (CEST – Central European Summer Time)
Duration: 1 hour
Monday to Thursday: 9-18h (UTC +1)
Friday: 9-15h (UTC +1)
Saturday and Sunday closed
Toll-free from the US: +18882012544
+34 932 800 836
+34 932 066 406
Legal regulations
Legal notice
Pº Manuel Girona, nº 32
Barcelona, España, CP 08034
The Institut Chiari & Siringomielia & Escoliosis de Barcelona (ICSEB) complies with the established in EU regulation 2016/679 (GDPR).
The contents of this website are a non-official translation of the original content of the website in Spanish. The translation is courtesy of the Institut Chiari & Siringomielia & Escoliosis de Barcelona with the purpose of facilitating comprehension for anyone who wishes to Access the website.